From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Shiying Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of BioPharmaceutical Research, Liaocheng University, Liaocheng, People's Republic of China. Hauptthemen laut MEDLINE: Indoleamine-Pyrrole 2,3,-Dioxygenase, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Natural Science Joint Foundation of Shandong Province, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Indoleamine 2,3‐dioxygenase‐1 (IDO‐1), as a crucial immunomodulatory target, plays a pivotal role in regulating immune function. In this study, the ligand‐based pharmacophore model (HDAA) and the receptor‐based pharmacophore model (HHDA) were respectively constructed, which could comprehensively reflect the spatial distribution characteristics of the core groups of IDO‐1 inhibitors. Subsequently, these pharmacophore models were utilized to guide the design of novel IDO‐1 inhibitors through a skeleton combination approach. The corresponding molecular structures were synthesized, and evaluated for their biological activities. Notably, compound 7b exhibited highly potent IDO‐1 inhibitory activity, which contributed to the body's immune activation in vivo. In summary, the study not only constructed the rational pharmacophore and docking models but also guided the development of novel IDO‐1 inhibitor skeletons, providing a promising approach to achieving immune activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of BioPharmaceutical Research, Liaocheng University, Liaocheng, People's Republic of China.
ORCID-Profile: Bin Sun
Förderung
- Natural Science Joint Foundation of Shandong Province
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhang, S., Zhang, A., & Sun, B. (2025). From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70207
Vancouver
Zhang S, Zhang A, Sun B. From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70207
BibTeX
@article{Zhang2025,
author = {Zhang, Shiying and Zhang, Anli and Sun, Bin},
title = {From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70207}
}
EUVIMED